138 related articles for article (PubMed ID: 2292034)
21. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
22. Genetics of nicotine response in four inbred strains of mice.
Marks MJ; Burch JB; Collins AC
J Pharmacol Exp Ther; 1983 Jul; 226(1):291-302. PubMed ID: 6864548
[TBL] [Abstract][Full Text] [Related]
23. The effects of acute nicotine on the body temperature and striatal dopamine metabolism of mice during chronic nicotine infusion.
Salminen O; Ahtee L
Neurosci Lett; 2000 Apr; 284(1-2):37-40. PubMed ID: 10771156
[TBL] [Abstract][Full Text] [Related]
24. Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors.
Collins AC; Evans CB; Miner LL; Marks MJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1767-73. PubMed ID: 3737641
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.
Molinari EJ; Delbono O; Messi ML; Renganathan M; Arneric SP; Sullivan JP; Gopalakrishnan M
Eur J Pharmacol; 1998 Apr; 347(1):131-9. PubMed ID: 9650859
[TBL] [Abstract][Full Text] [Related]
26. Prenatal nicotine alters nicotinic receptor development in the mouse brain.
van de Kamp JL; Collins AC
Pharmacol Biochem Behav; 1994 Apr; 47(4):889-900. PubMed ID: 8029259
[TBL] [Abstract][Full Text] [Related]
27. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment.
Marks MJ; Pauly JR; Gross SD; Deneris ES; Hermans-Borgmeyer I; Heinemann SF; Collins AC
J Neurosci; 1992 Jul; 12(7):2765-84. PubMed ID: 1613557
[TBL] [Abstract][Full Text] [Related]
28. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice.
Collins AC; Romm E; Selvaag S; Turner S; Marks MJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1390-7. PubMed ID: 8371144
[TBL] [Abstract][Full Text] [Related]
30. The effect of chronic nicotine treatment on nicotine-induced seizures.
Miner LL; Collins AC
Psychopharmacology (Berl); 1988; 95(1):52-5. PubMed ID: 3133700
[TBL] [Abstract][Full Text] [Related]
31. Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects.
Irvine EE; Cheeta S; Marshall M; File SE
Pharmacol Biochem Behav; 2001 Apr; 68(4):769-76. PubMed ID: 11526975
[TBL] [Abstract][Full Text] [Related]
32. An analysis of response to nicotine infusion using an automated radiotelemetry system.
Robinson SF; Pauly JR; Marks MJ; Collins AC
Psychopharmacology (Berl); 1994 Jun; 115(1-2):115-20. PubMed ID: 7862882
[TBL] [Abstract][Full Text] [Related]
33. Long-term ethanol and nicotine treatment elicit tolerance to ethanol.
Collins AC; Wilkins LH; Slobe BS; Cao JZ; Bullock AE
Alcohol Clin Exp Res; 1996 Sep; 20(6):990-9. PubMed ID: 8892517
[TBL] [Abstract][Full Text] [Related]
34. Nicotine physical dependence and tolerance in the mouse following chronic oral administration.
Grabus SD; Martin BR; Batman AM; Tyndale RF; Sellers E; Damaj MI
Psychopharmacology (Berl); 2005 Mar; 178(2-3):183-92. PubMed ID: 15365686
[TBL] [Abstract][Full Text] [Related]
35. Classical genetic analysis of nicotine-induced seizures and nicotinic receptors.
Miner LL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1984 Dec; 231(3):545-54. PubMed ID: 6502513
[TBL] [Abstract][Full Text] [Related]
36. Binding differences between nicotine and alpha-bungarotoxin in the rat brain.
Nukina I; Ogawa N; Takayama H; Ota Z
Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):141-4. PubMed ID: 2858912
[TBL] [Abstract][Full Text] [Related]
37. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
Marks MJ; Collins AC
Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
[TBL] [Abstract][Full Text] [Related]
38. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment.
Pauly JR; Marks MJ; Gross SD; Collins AC
J Pharmacol Exp Ther; 1991 Sep; 258(3):1127-36. PubMed ID: 1890617
[TBL] [Abstract][Full Text] [Related]
39. Prenatal nicotine exposure: effects on locomotor activity and central [125I]alpha-BT binding in rats.
Tizabi Y; Russell LT; Nespor SM; Perry DC; Grunberg NE
Pharmacol Biochem Behav; 2000 Jul; 66(3):495-500. PubMed ID: 10899361
[TBL] [Abstract][Full Text] [Related]
40. Regulation of brain nicotinic receptors by chronic agonist infusion.
Bhat RV; Turner SL; Selvaag SR; Marks MJ; Collins AC
J Neurochem; 1991 Jun; 56(6):1932-9. PubMed ID: 2027007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
